focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
News tomorrow?
Possibly cashing out for CGT loss or move to ISA
could see news drop next week or so
conference last day.
https://informaconnect.com/bioeurope-spring/
400% is positive - 4% is of no significance
ticking up on Nasdaq
4%
thats positive
Love your positivity but give it a rest mate
OK not getting 10 bagger today, buy my word, Collaborations with Johnson & Johnson pharmaceutical (Janssen)
and the findings is awesome!!
" The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling"
is there any better opportunity than Midatech on AIM right now?
MTPH Cash £10M
Mcap £13M
MTPH Cash £10M
Mcap £13M
listen from 17 min 30 sec onwards for financial summary.
of course Worth a careful listen to the whole of the video to grasp the enormity of Midatech Pharma
https://youtu.be/SgE_7nex6Yk
MTPH Cash £10M
Mcap £13M
listen from 17 min 30 sec onwards is for financial summary.
of course Worth a careful listen to the whole of the video to grasp the enormity of Midatech Pharma
https://youtu.be/SgE_7nex6Yk
as per Rns on 9th March Janssen (Johnson & Johnson pharmaceutical company) collaboration looking good.
The most exciting play on AIM goes to this £13M Mcap company with £10m cash is @Midatech and MTPH
Huge commercial deal coming
The most exciting play on AIM goes to this £13M Mcap company with £10m cash is @Midatech and MTPH
Huge commercial deal coming
20 bagd only... that's a bit conservative for you... versus previous form on other boards :-)
This time next year Rodders !
had a I known the basic metrics to do calculations I would have done it, however with Pharmaceutical companies it's about how big the drug market is, for MTPH it's about how effective the drug delivery system is.
I would say on deal news MTPH could do 20 Bagger because of the low Mcap of £13M
******£260M is 20 Bagger ******
how about you buy 5k gbp worth of these doggy's for every post you make here EarlofAIm ? :-)
(it would help the s/p no end and help stop you posting just for the sake of it here too.. )
ps surprised you haven't yet hit us with a post saying this is worth 5gbp a share by your calcuations.. staying true to other form you have :-)
someone loading up
not suprise,
Undervalued and under the radar company.
cashed up £10M, and Mcap £13M
taken from Rns 9 March
someone knows what's coming
looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."
massive collaboration with one of the leading companies in the industry!!
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,
....
taken from Rns 9 March
someone knows what's coming
looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."
massive collaboration with one of the leading companies in the industry!!
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,
someone knows what's coming
looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."
massive collaboration with one of the leading companies in the industry!!
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,
finally some movement here! Just need the US to get it together
massive collaboration with one of the leading companies in the industry!!
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,
…suddenly after a glut of trades out of the blue, usually means a large trade is being worked through. Look out for some OOO trades around 13.75p when this closes at 15p+
Let see if they can get a deal, they seem quite confident that they will and boom time if they can.
get ready for commercial scaling...
looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."
Midatech Pharma PLC (AIM: MTPH; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21 July 2020.
On 17 June 2021 the Company announced that, using its Q-Sphera technology, it had successfully encapsulated a proprietary Janssen experimental large molecule medicine and importantly preserved its functional integrity. The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling.